Wihuri Research Institute, a non-profit biomedical institute in Helsinki, drives fundamental research on vascular biology to advance human health. www.wri.fi
Wihuri Research Institute
Loading...
New study from Pipsa Saharinen’s lab @pipsasaharinen.bsky.social at #WRIHelsinki, featured on the cover of @jci.org: Integrin conformational switching regulates ANGPT2/TIE2/FOXO1 signaling at endothelial cell junctions.👇
New study from Taija Mäkinen's lab @taijamakinenlab.bsky.social at the #WRIHelsinki discovering an essential role for the major angiogenic receptor VEGFR2 in lymphangiogenesis 👇 tinyurl.com/47bns9pp
Register early (online below) to secure your place!
wri.fi/symposia/sym...
Registration is open for the annual Wihuri Research Institute Symposium at Hanasaari Conference Centre in Helsinki on 18 August 2026.
Join us for a day of cutting-edge science, engaging discussions and networking.
Deadline for registration and abstract submission: 19 June.
The work was carried out under the supervision of Prof. Katariina Öörni, with Prof. Paolo Parini from Karolinska Institutet as an inspiring opponent and Prof. Katariina Öörni serving as custos.
Congratulations to Dr. Lauri Äikäs on successfully defending his PhD thesis "Improving the Lipidome of Low-Density Lipoproteins via Dietary Intervention to Reduce Their Proatherogenic Properties" on 24 April 2026!
Congratulations to Dr. Ibrahim Sultan on successfully defending his PhD thesis "Translational insights into VEGF-B gene therapy" today! The work was carried out under the supervision of Prof. Kari Alitalo, with Prof. Holger Gerhardt as an inspiring opponent and Prof. Karl Lemström serving as custos.
New study from Kati Öörni’s lab @katioorni.bsky.social at #WRIHelsinki on the effect of icosapent ethyl (IPE) on circulating lipoproteins and their pro-atherogenic properties.👇
New study from Taija Mäkinen's lab @taijamakinenlab.bsky.social at the #WRIHelsinki featured on the cover of @natcardiovascres.nature.com: A ‘feedforward’ circuit amplifying upstream TIE2 receptor signalling drives PIK3CA-driven venous malformation - and can be therapeutically targeted in mice.👇
New study from Riikka Kivelä's lab @riikka-k.bsky.social at the #WRIHelsinki: Combined gene therapy with Pro-MSTN and VEGF-B boosts muscle growth and improves body composition.👇
journals.physiology.org/doi/abs/10.1...